KIT and oncocytic adenoma: Machine learning has demonstrated high accuracy in distinguishing CD117 (c-KIT) oncocytomas from the chromophobe subtype of renal cell carcinoma using the peak early enhancement rate (PEER), with a 95% accuracy for tumor type classification (100% sensitivity and 89% specificity) [66].